Ars Pharmaceuticals Inc (SPRY)

Sales/Maturities of Investments

$61.48M

Quarterly · Period ending: · USD

SPRY logo

SPRY Sales/Maturities of Investments

Latest reported$61.48M
SPRY Quarterly Sales/Maturities of Investments ($0.00 → $61.48M)
High-resolution chart · PNG

SPRY sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ars Pharmaceuticals Inc Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
61,484,000
42,500,000
75,000,000
88,500,000
80,000,000
63,500,000
67,000,000
61,000,000
75,000,000
55,000,000
60,000,000
60,000,000
45,000,000
20,000,000
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.